Peer Review History
| Original SubmissionMay 26, 2022 |
|---|
|
PONE-D-22-15026The General Hopelessness Scale: Development of a measure for non-clinical samples PLOS ONE Dear Dr. Ken Drinkwater, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript is relevant and presents a new psychometric measure of hopelessness. However, to accept the manuscript, it is recommended to consider the adjustments requested by the reviewers and, here, endorsed. First, a much better way to guide your research is to address a scientific problem related to a relevant problem. Successful manuscripts usually answer at least one of the following questions: Is it a solution to an established and relevant problem? Is it an extension of a well-known technique? Is your contribution improving a technique or methodology? In any case, the literature review must clearly explain where your contribution fits. Second, the abstract needs to present the participants, specifying pertinent characteristics, such as age, sex, and ethnic and/or racial group; the essential characteristics of the study method - particularly those most likely to be used in electronic searches; the main results, including effect sizes and confidence intervals and/or levels of statistical significance; and conclusions and implications or applications. Third, for the methods and results sections, please refer to the APA recommendations. For more details, see: Appelbaum, M., Cooper, H., Kline, R. B., Mayo-Wilson, E., Nezu, A. M., & Rao, S. M. (2018). Journal article reporting standards for quantitative research in psychology: The APA Publications and Communications Board task force report. American Psychologist, 73(1), 3–25. https://doi.org/10.1037/amp0000191. Also, consider updating the reference for the cutoffs used for CFA. For more details, see: van Laar, S., & Braeken, J. (2022). Caught off Base: A Note on the Interpretation of Incremental Fit Indices. Structural Equation Modeling: A Multidisciplinary Journal, 29(6), 935–943. https://doi.org/10.1080/10705511.2022.2050730. Four, for data analysis and results. 1. Confirmatory Factor Analysis (CFA). Due to the ordinal nature of dataset and non-normal distribution, it is recommended to use a Weighted Least Squares Mean and Variance-Adjusted (WLSMV) estimator with polychoric matrices for performing the CFA. For more details, see: DiStefano, C., & Morgan, G. B. (2014). A Comparison of Diagonal Weighted Least Squares Robust Estimation Techniques for Ordinal Data. Structural Equation Modeling: A Multidisciplinary Journal, 21(3), 425–438. https://doi.org/10.1080/10705511.2014.915373 2. Rasch analysis. Due to the ordinal nature of the data set, it is necessary to fit the analysis to the gradation response model. Is a mathematical model family that deals with ordered polytomous categories. These ordered categories include ratings such as strongly disagree, disagree, agree, and strongly agree, which are used in the manuscript. For more details, see: Samejima, F. (2016). Graded response models. In Handbook of item response theory, volume one (pp. 123-136). Chapman and Hall/CRC. Furthermore, it is necessary to consider the discrimination ("a" parameter). Because the goal of most psychometric measures is to distinguish between examinees, items with higher discriminations ("a" parameter) are frequently regarded as better. Items with very low parameters provide minimal measurement information and might be considered for change or removal. Finally, once you have revised the manuscript, check it. Are all fonts visible, particularly in equations? Is numbering consistent across sections, figures, tables, etc.? Are all references, figures, and tables cited? Are all the references listedcited? Are all the figures and tables cited? Please submit your revised manuscript by Mar 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jorge Artur Peçanha de Miranda Coelho Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please change "female” or "male" to "woman” or "man" as appropriate, when used as a noun (see for instance https://apastyle.apa.org/style-grammar-guidelines/bias-free-language/gender)." 3. Peer review at PLOS ONE is not double-blinded (https://journals.plos.org/plosone/s/editorial-and-peer-review-process). For this reason, authors should include in the revised manuscript all the information removed for blind review. 4. Please provide further information on how participants were selected/recruited" 5. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the manuscript "The General Hopelessness Scale: Development of a measure for non-clinical samples", the authors developed a new instrument to measure hopelessnes, aming to better discriminate between lower levels of hopelessness. In general the topic of this manuscript is interesting for readers of this journal, the analyses are according to high standards, and the paper is written clear and nicely. I have only two remarks: - It would be good to also develop a short scale with 1-3 items per dimension to allow an effective and quick measurement in big panel surveys. - Maybe an unpopular opinion and also not really constructive, but does the (scientific) world really need a measure of hopelessness? We have pretty good (and short) screening intruments for depression. Locus of control is also a very similar concept. So, what is the major advantage of measuring hopelessness? Why do we need to include this in our surveys? Signed, David Richter. Reviewer #2: The manuscript reviewed here aimed at presenting the development of a novel measure of hopelesness, based on Beck's cognitive theory of depression, that could be used to non-clinical samples. I do believe the studies presented are interesting and novel, showing a promising measure that could be used for research and also for therapeutic purposes, in order to understand an individual's beliefs regarding their own level of hope / hopelesness. However, I also believe the manuscript is not ready for publication, as it needs further development in the introduction and to change the softwares used in the analyses. Please, see my comments below. ABSTRACT * It doesn't present sample information. The abstract should contain information regarding sample, instruments and results. INTRODUCTION * Introduction is short on presenting the main concept of the paper, which is Hopelesness. Only one paragraph presents something about it before presenting the BHS. I believe a few more paragraphs explaining its importance and nomological network might be useful to locate the reader regarding the current study of the topic. * The authors make interesting comments on the different structures observed in the literature and the limitations of using the BHS in non-clinical populations. * The paper also justifies accordingly the need to develop a non-clinical hopelesness instrument, for which I commend the authors. METHODS * Participants and instruments are presented objectively, with all necessary information. However, there is no information on how the study was presented to potential participants or how they came to know about the study. Was there any inclusion / exclusion criteria for participant selection? Procedures paragraph should include this information. RESULTS * I do believe the most recent algorithms for conducting a proper EFA are included in the FACTOR software, especially when involving the discussion regarding items on psychological instruments being ordinal and not scalar items. In this case, I suggest the authors change the software used in the EFA from SPSS to FACTOR. * Also regarding the CFA, the AMOS software also doesn't include the most recent algorithms for these analyses. Softwares such as JASP, JAMOVI or the R language are much improved when compared to AMOS. * For both comments here regarding the softwares, there might be no difference in the results, but we would be sure the analyses were conducted using the best softwares we have nowadays. * Table 2 doesn't present the results the best way possible. We need to see all factor loadings in all dimensions to visualize its distribution. * Why the term futility was used to describe "an individual's aversion to initiate or maintain new behaviours"? In current language, the term futility would be describing something trivial or pointless. I do understand the term emphasizes the individual's belief that changing or maintaning change is ineffective or fruitless. However, the definition is "aversion to initiate or maintain new behaviors". For me, the emphasis in this sentence is the aversion and not what the individual uses to justify their own aversion (the pointlessness of trying). This is only to think about as the terms we choose to describe the dimensions are important as they carry the meaning of the psychological construct underlying the items. * Also, regarding the meaning of the items presented in Table 2 and their attributed dimension, I have a few doubts regarding their belonging to that definition. To exemplify, see below: - Item 7 describes everything as pointless. Why is this item in the Social Comparison dimension and not in the Futility dimension, like the item 8? - Item 9 is a clear case of Social Comparison, but why does the item 10 belong in the same dimension? Where is the social comparison in this case? Same question apply for items 11 and 16. DISCUSSION * I see a little bit of a discussion regarding the term 'futility' in the discussion session, which is very interesting. However, my comment remains on why calling it 'Futility' and not "Aversion to change" or "Lack of intrinsic motivation"? * A more detailed paragraph on future studies regarding the potential use of the new measure is also lacking. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: David Richter Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The General Hopelessness Scale: Development of a measure for non-clinical samples PONE-D-22-15026R1 Dear Dr. Drinkwater, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Karl Bang Christensen, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for revising Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors did a fine job with the revisionand addressed all my comments. At this point, I have no futher comments. Reviewer #2: The new revised version of the paper adressed all my comments from the previous round. The only thing missing for me is the Figure 1, which did not appear in my pdf version of the manuscript. However, it is possible to infer its quality, considering the main numbers are described in the text. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-22-15026R1 The General Hopelessness Scale: Development of a measure of hopelessness for non-clinical samples Dear Dr. Drinkwater: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Karl Bang Christensen Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .